Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Adverse effects
[56] RCT 3-armed trial	94 people	Adverse effects with repifermin (at either dose) with placebo Absolute results not reported	Reported as not significant The RCT may have lacked power to detect a clinically important difference between groups		Not significant